Promoter demethylation mediates the expression of ZNF645, a novel cancer/testis gene
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Cancer/testis (CT) antigens exhibit highly tissue-restricted expression and are considered promising targets for cancer vaccines. Here we identified a novel CT gene ZNF645 which restrictively expresses in normal human testes and lung cancer patients (68.3%). To investigate the promoter methylation status of ZNF645, we carried out bisulfite genomic sequencing and found that the CpG island in its promoter was heavily methylated in normal lung tissues without the expression of ZNF645, whereas there was high demethylation in normal human testes and lung carcinoma tissues with its expression. Also ZNF645 could be remarkably activated in A549 and HEK293T cells treated by DNA demethylation agent 5'-aza-2'-deoxycytidine. And the dual luciferase assay revealed that the promoter activity of the ZNF645 was inhibited by methylation of the CpG island region. Therefore, we proposed that ZNF645is a CT gene and activated in human testis and lung cancers by demethylation of its promoter region.
Abstract
Cancer/testis (CT) antigens exhibit highly tissue-restricted expression and are considered promising targets for cancer vaccines. Here we identified a novel CT gene ZNF645 which restrictively expresses in normal human testes and lung cancer patients (68.3%). To investigate the promoter methylation status of ZNF645, we carried out bisulfite genomic sequencing and found that the CpG island in its promoter was heavily methylated in normal lung tissues without the expression of ZNF645, whereas there was high demethylation in normal human testes and lung carcinoma tissues with its expression. Also ZNF645 could be remarkably activated in A549 and HEK293T cells treated by DNA demethylation agent 5'-aza-2'-deoxycytidine. And the dual luciferase assay revealed that the promoter activity of the ZNF645 was inhibited by methylation of the CpG island region. Therefore, we proposed that ZNF645is a CT gene and activated in human testis and lung cancers by demethylation of its promoter region.
참고문헌 (31)
- Scanlan, M., "Cancer", testis antigens: an expanding family of targets for cancer immunotherapy, 2002, pp.188, 22~32
- Scanlan, M., "The cancer", testis genes: review, standardization, and commentary, 2004, pp.4, 1~
- van der Bruggen, P., "A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma", Science, 254, pp.1643~1647 (1991)
- Ross, M., "The DNA sequence of the human X chromosome", Nature, 434, pp.325~337 (2005)
- Hofmann, O., "Genome-wide analysis of cancer", testis gene expression, 2008, pp.통권 : 105, 20422~20427
- Tajima, K., "Expression of cancer", testis (CT) antigens in lung cancer, 2003, pp.42, 23~33
- Bird, A., "Methylation-induced repression--belts, braces, and chromatin", Cell., 99, pp.451~454 (1999)
- Cedar, H., "DNA methylation and gene activity", Cell., 53, pp.3~4 (1988)
- Bird, A., "DNA methylation patterns and epigenetic memory", Genes. Dev., 16, pp.6~21 (2002)
- Simpson, A., "Cancer", testis antigens, gametogenesis and cancer, 2005, pp.5, 615~625
- De Smet, C., "DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter", Mol. Cell. Biol., 19, pp.7327~7335 (1999)
- Grunwald, C., "Expression of multiple epigenetically regulated cancer", germline genes in nonsmall cell lung cancer, 2006, pp.118, 2522~2528
- Sigalotti, L., "Intratumor heterogeneity of cancer", testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine, 2004, pp.64, 9167~9171
- Antequera, F., "CpG islands", EXS., 64, pp.169~185 (1993)
- Antequera, F., "Number of CpG islands and genes in human and mouse", Proc. Natl. Acad. Sci. U.S.A., 통권 : 90, pp.11995~11999 (1993)
- Dong, X., "Zincfinger protein ZNF165 is a novel cancer-testis antigen capable of eliciting antibody response in hepatocellular carcinoma patients", Br. J. Cancer, 91, pp.1566~1570 (2004)
- Loukinov, D., "BORIS, a novel male germline-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma", Proc. Natl. Acad. Sci. U.S.A., 통권 : 99, pp.6806~6811 (2002)
- Lim, F., "A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas", Oncogene., 17, pp.2013~2018 (1998)
- Gama-Sosa, M., "The 5-methylcytosine content of DNA from human tumors", Nucleic. Acids. Res., 11, pp.6883~6894 (1983)
- del Mazo, J., "DNA methylation changes during mouse spermatogenesis", Chromosome Res., 2, pp.147~152 (1994)
- Zhu, J., "Use of DNA methylation for cancer detection and molecular classification", J. Biochem. Mol. Biol., 40, pp.135~141 (2007)
- Jones, P., "The fundamental role of epigenetic events in cancer", Nat. Rev. Genet., 3, pp.415~428 (2002)
- Sasaki, H., "Epigenetic events in mammalian germ-cell development: reprogramming and beyond", Nat. Rev. Genet., 9, pp.129~140 (2008)
- Jones, P., "The role of DNA methylation in mammalian epigenetics", Science, 293, pp.1068~1070 (2001)
- De Smet, C., "The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation", Proc. Natl. Acad. Sci. U.S.A., 통권 : 93, pp.7149~7153 (1996)
- Iguchi-Ariga, S., "CpG methylation of the cAMP-responsive enhancer", promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation, 1989, pp.3, 612~619
- Coral, S., "5-aza-2'-deoxycytidine-in duced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications", Clin. Cancer. Res., 8, pp.2690~2695 (2002)
- Christman, J., "5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy", Oncogene., 21, pp.5483~5495 (2002)
- James, S., "Epigenetic regulation of X-linked cancer", germline antigen genes by DNMT1 and DNMT3b, 2006, pp.25, 6975~6985
- Coral, S., "Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2'-deoxycytidine (5-AZA-CdR)", J. Immunother, 22, pp.16~24 (1999)
- Sambrook, J., "Molecular Cloning: A Laboratory Manual, 2nd ed" (1989), Cold Spring Harbor Laboratory Press